Relative Strength Stocks
Par Pacific Holdings: From Regional Oil Supplier to Green Fuel Pioneer
Phillips 66: Substantive Energy Stock with Future Prospects
As a leading downstream energy company, Phillips 66 refines crude oil at its own refineries and sells...
Kodiak Sciences: Tackling the Global Blindness Threat
Kodiak Sciences is developing innovative biologics for the treatment of serious retinal diseases leading...
Iovance Biotherapeutics: The Pioneer of Personalized Cancer Therapy on the Brink of Breakthrough
Iovance Biotherapeutics has a first-mover advantage, as the company has commercialized Amtagvi, the...
AMD: The Rise into the Trillion-Dollar Club
AMD is fully focused on the design of cutting-edge processors and has them manufactured cost-effectively...
Semtech: The Unassuming Winner in the Shadow of AI Giants
Semtech benefits disproportionately from the expansion of modern data centers, as its specialized...
Guardant Health: Cancer Detection via Blood Sample - Here's how the Company is Revolutionizing the Diagnostic Market
Guardant Health is a pioneer in liquid-based cancer testing, detecting genetic tumor traces painlessly...
PBF Energy: The Crude Oil Refiner - How to Squeeze Clean Returns from Dirty Oil
PBF Energy focuses completely on the refining of crude oil and downstream logistics as an independent...
Kymera Therapeutics: The Biotech Company Is Taking on Billion-Dollar Markets with Targeted Protein Destruction
Through targeted protein degradation, Kymera utilizes a biological recycling system that completely...
CG Oncology: The Million-Dollar Bet on the Bladder Cancer Breakthrough
CG Oncology is a late-stage biopharma company focusing on the development of a bladder-preserving...
Travere Therapeutics: The Covert Monopoly in the Kidney Market
Travere Therapeutics owns the first and only approved therapy for the rare kidney disease FSGS with...
Moderna: From Pandemic Beneficiary to Cancer Pioneer
Moderna operates a programmable mRNA platform that enables rapid development of medical blueprints...
Arrowhead Pharmaceuticals: Targeting the Genome Rocket: How to Reprogram Medicine
Arrowhead Pharmaceuticals develops highly precise RNAi therapeutics that directly target and silence...
Twist Bioscience: The DNA Factory Approaching an Operational Turning Point
Twist Bioscience has revolutionized DNA manufacturing by printing genetic building blocks on proprietary...
Praxis Precision Medicines: Between FDA Approval and Billion-Dollar Market
Praxis Precision Medicines is a US biopharmaceutical company that researches therapies for severe...
BrightSpring Health Services: The Silent Giant in the US Care Market
BrightSpring combines specialized pharmaceutical care with qualified home healthcare and generates...
Revolution Medicines: The Attack on the Unbreakable Cancer Code
Revolution Medicines develops novel compounds that specifically block the active form of cancer-causing...
10x Genomics: Technology Leader in Next-Generation Genomics
The high-margin "razor-and-blades business model" provides the technology leader with reliable, recurring...
Liquidia Corporation: From Treprostinil Pioneer to Highly Profitable Pharma Player
Liquidia utilizes its patented PRINT® platform to transform established active ingredients like Treprostinil...
Victoria’s Secret & Co.: Rise, Fall, and Resurrection
The radical image shift away from the "Angels" towards comfort and inclusion has breathed new life...
Fastly: The Edge Revolution: Is the Company now Starting its Second Spring?
Fastly accelerates the internet and secures web applications by processing data through a decentralized...
Erasca: Here's how the Biotech Company Aims to Revolutionize Oncology
Erasca is a pure development company in precision oncology that currently has no products on the market...
Ciena Corp.: The Indispensable Giant in the Shadow of AI Titans
Ciena benefits massively as the physical "nervous system" from the AI boom, as the company provides...
Nektar Therapeutics: Full Focus on the Billion-Dollar Market of Immunology
Nektar Therapeutics generates its revenue not from selling its own medications, but from the research...